| . | All (n = 310) . | GroupA (n = 98) . | GroupB (n = 212) . | P-Value . |
|---|---|---|---|---|
| Age (years), mean (SD) | 56.3 (13.6) | 55.0 (12.3) | 56.9 (14.1) | 0.26 |
| Female, n (%) | 74 (23.9) | 23 (23.5) | 51 (24.1) | 0.91 |
| Height (cm), mean (SD) | 174.5 (9.5) | 174.4 (9.0) | 174.6 (9.7) | 0.87 |
| Weight (kg), mean (SD) | 94.7 (25.4) | 95.6 (26.8) | 94.3 (24.8) | 0.66 |
| BSA, mean (SD) | 2.08 (0.3) | 2.08 (0.3) | 2.08 (0.3) | 0.86 |
| Hypertension, n (%) | 223 (71.9) | 67 (68.4) | 156 (73.6) | 0.34 |
| Dyslipidaemia, n (%) | 167 (53.9) | 47 (48.0) | 120 (56.6) | 0.16 |
| Diabetes mellitus, n (%) | 131 (42.3) | 38 (38.8) | 93 (43.9) | 0.40 |
| CVA, n (%) | 48 (15.5) | 14 (14.3) | 34 (16.0) | 0.69 |
| COPD, n () | 72 (23.2) | 18 (18.4) | 54 (25.5) | 0.16 |
| PVD, n (%) | 27 (8.7) | 3 (3.1) | 24 (11.3) | <0.01 |
| CHADS2 score, mean (SD) | 2.52 (1.1) | 2.40 (1.1) | 2.58 (1.1) | 0.19 |
| IABP, n (%) | 94 (30.3) | 29 (29.6) | 65 (30.7) | 0.85 |
| ECMO, n (%) | 18 (5.8) | 8 (8.2) | 10 (4.7) | 0.24 |
| HeartMate 3, n (%) | 137 (44.2) | 52 (53.1) | 85 (40.1) | 0.03 |
| History of atrial fibrillation, n (%) | 132 (42.6) | 42 (42.9) | 90 (42.5) | 0.95 |
| Previous cardiac surgery, n (%) | 75 (24.2) | 5 (5.1) | 70 (33.0) | <0.01 |
| Antiplatelet, n (%) | 161 (51.9) | 49 (50.0) | 112 (52.8) | 0.64 |
| Anticoagulation, n (%) | 152 (49.0) | 43 (43.9) | 109 (51.4) | 0.22 |
| Creatinin (mg/dl), mean (SD) | 1.56 (0.7) | 1.56 (0.8) | 1.56 (0.7) | 0.98 |
| LVDd (mm), mean (SD) | 70.6 (11.5) | 71.1 (11.4) | 70.4 (11.6) | 0.63 |
| Ejection fraction (%), mean (SD) | 19.7 (6.4) | 19.6 (6.4) | 19.7 (6.5) | 0.87 |
| Bridged to transplant, n (%) | 49 (15.8) | 16 (16.3) | 33 (15.6) | 0.46 |
| CVP (mmHg), mean (SD) | 13.8 (7.0) | 14.5 (7.0) | 13.5 (7.0) | 0.26 |
| Mean PAP (mmHg), mean (SD) | 38.9 (11.1) | 40.6 (11.1) | 38.1 (11.0) | 0.09 |
| PAWP (mmHg), mean (SD) | 26.4 (9.1) | 27.5 (8.6) | 25.9 (9.3) | 0.18 |
| PVR, mean (SD) | 3.66 (2.5) | 3.76 (2.5) | 3.62 (2.5) | 0.70 |
| CI (l/min/m2), mean (SD) | 1.89 (0.6) | 1.91 (0.5) | 1.89 (0.6) | 0.70 |
| . | All (n = 310) . | GroupA (n = 98) . | GroupB (n = 212) . | P-Value . |
|---|---|---|---|---|
| Age (years), mean (SD) | 56.3 (13.6) | 55.0 (12.3) | 56.9 (14.1) | 0.26 |
| Female, n (%) | 74 (23.9) | 23 (23.5) | 51 (24.1) | 0.91 |
| Height (cm), mean (SD) | 174.5 (9.5) | 174.4 (9.0) | 174.6 (9.7) | 0.87 |
| Weight (kg), mean (SD) | 94.7 (25.4) | 95.6 (26.8) | 94.3 (24.8) | 0.66 |
| BSA, mean (SD) | 2.08 (0.3) | 2.08 (0.3) | 2.08 (0.3) | 0.86 |
| Hypertension, n (%) | 223 (71.9) | 67 (68.4) | 156 (73.6) | 0.34 |
| Dyslipidaemia, n (%) | 167 (53.9) | 47 (48.0) | 120 (56.6) | 0.16 |
| Diabetes mellitus, n (%) | 131 (42.3) | 38 (38.8) | 93 (43.9) | 0.40 |
| CVA, n (%) | 48 (15.5) | 14 (14.3) | 34 (16.0) | 0.69 |
| COPD, n () | 72 (23.2) | 18 (18.4) | 54 (25.5) | 0.16 |
| PVD, n (%) | 27 (8.7) | 3 (3.1) | 24 (11.3) | <0.01 |
| CHADS2 score, mean (SD) | 2.52 (1.1) | 2.40 (1.1) | 2.58 (1.1) | 0.19 |
| IABP, n (%) | 94 (30.3) | 29 (29.6) | 65 (30.7) | 0.85 |
| ECMO, n (%) | 18 (5.8) | 8 (8.2) | 10 (4.7) | 0.24 |
| HeartMate 3, n (%) | 137 (44.2) | 52 (53.1) | 85 (40.1) | 0.03 |
| History of atrial fibrillation, n (%) | 132 (42.6) | 42 (42.9) | 90 (42.5) | 0.95 |
| Previous cardiac surgery, n (%) | 75 (24.2) | 5 (5.1) | 70 (33.0) | <0.01 |
| Antiplatelet, n (%) | 161 (51.9) | 49 (50.0) | 112 (52.8) | 0.64 |
| Anticoagulation, n (%) | 152 (49.0) | 43 (43.9) | 109 (51.4) | 0.22 |
| Creatinin (mg/dl), mean (SD) | 1.56 (0.7) | 1.56 (0.8) | 1.56 (0.7) | 0.98 |
| LVDd (mm), mean (SD) | 70.6 (11.5) | 71.1 (11.4) | 70.4 (11.6) | 0.63 |
| Ejection fraction (%), mean (SD) | 19.7 (6.4) | 19.6 (6.4) | 19.7 (6.5) | 0.87 |
| Bridged to transplant, n (%) | 49 (15.8) | 16 (16.3) | 33 (15.6) | 0.46 |
| CVP (mmHg), mean (SD) | 13.8 (7.0) | 14.5 (7.0) | 13.5 (7.0) | 0.26 |
| Mean PAP (mmHg), mean (SD) | 38.9 (11.1) | 40.6 (11.1) | 38.1 (11.0) | 0.09 |
| PAWP (mmHg), mean (SD) | 26.4 (9.1) | 27.5 (8.6) | 25.9 (9.3) | 0.18 |
| PVR, mean (SD) | 3.66 (2.5) | 3.76 (2.5) | 3.62 (2.5) | 0.70 |
| CI (l/min/m2), mean (SD) | 1.89 (0.6) | 1.91 (0.5) | 1.89 (0.6) | 0.70 |
BSA: body surface area; CI: cardiac index; COPD: chronic obstructive pulmonary disease; CVA: cerebrovascular accident; CVP: central venous pressure; ECMO: extracorporeal membranous oxygenation; IABP: intra-aortic balloon pump; LVDd: left ventricular end-diastolic diameter; PAP: pulmonary artery pressure; PAWP: pulmonary artery wedge pressure; PVD: peripheral vascular disease; PVR: pulmonary vascular resistance.
| . | All (n = 310) . | GroupA (n = 98) . | GroupB (n = 212) . | P-Value . |
|---|---|---|---|---|
| Age (years), mean (SD) | 56.3 (13.6) | 55.0 (12.3) | 56.9 (14.1) | 0.26 |
| Female, n (%) | 74 (23.9) | 23 (23.5) | 51 (24.1) | 0.91 |
| Height (cm), mean (SD) | 174.5 (9.5) | 174.4 (9.0) | 174.6 (9.7) | 0.87 |
| Weight (kg), mean (SD) | 94.7 (25.4) | 95.6 (26.8) | 94.3 (24.8) | 0.66 |
| BSA, mean (SD) | 2.08 (0.3) | 2.08 (0.3) | 2.08 (0.3) | 0.86 |
| Hypertension, n (%) | 223 (71.9) | 67 (68.4) | 156 (73.6) | 0.34 |
| Dyslipidaemia, n (%) | 167 (53.9) | 47 (48.0) | 120 (56.6) | 0.16 |
| Diabetes mellitus, n (%) | 131 (42.3) | 38 (38.8) | 93 (43.9) | 0.40 |
| CVA, n (%) | 48 (15.5) | 14 (14.3) | 34 (16.0) | 0.69 |
| COPD, n () | 72 (23.2) | 18 (18.4) | 54 (25.5) | 0.16 |
| PVD, n (%) | 27 (8.7) | 3 (3.1) | 24 (11.3) | <0.01 |
| CHADS2 score, mean (SD) | 2.52 (1.1) | 2.40 (1.1) | 2.58 (1.1) | 0.19 |
| IABP, n (%) | 94 (30.3) | 29 (29.6) | 65 (30.7) | 0.85 |
| ECMO, n (%) | 18 (5.8) | 8 (8.2) | 10 (4.7) | 0.24 |
| HeartMate 3, n (%) | 137 (44.2) | 52 (53.1) | 85 (40.1) | 0.03 |
| History of atrial fibrillation, n (%) | 132 (42.6) | 42 (42.9) | 90 (42.5) | 0.95 |
| Previous cardiac surgery, n (%) | 75 (24.2) | 5 (5.1) | 70 (33.0) | <0.01 |
| Antiplatelet, n (%) | 161 (51.9) | 49 (50.0) | 112 (52.8) | 0.64 |
| Anticoagulation, n (%) | 152 (49.0) | 43 (43.9) | 109 (51.4) | 0.22 |
| Creatinin (mg/dl), mean (SD) | 1.56 (0.7) | 1.56 (0.8) | 1.56 (0.7) | 0.98 |
| LVDd (mm), mean (SD) | 70.6 (11.5) | 71.1 (11.4) | 70.4 (11.6) | 0.63 |
| Ejection fraction (%), mean (SD) | 19.7 (6.4) | 19.6 (6.4) | 19.7 (6.5) | 0.87 |
| Bridged to transplant, n (%) | 49 (15.8) | 16 (16.3) | 33 (15.6) | 0.46 |
| CVP (mmHg), mean (SD) | 13.8 (7.0) | 14.5 (7.0) | 13.5 (7.0) | 0.26 |
| Mean PAP (mmHg), mean (SD) | 38.9 (11.1) | 40.6 (11.1) | 38.1 (11.0) | 0.09 |
| PAWP (mmHg), mean (SD) | 26.4 (9.1) | 27.5 (8.6) | 25.9 (9.3) | 0.18 |
| PVR, mean (SD) | 3.66 (2.5) | 3.76 (2.5) | 3.62 (2.5) | 0.70 |
| CI (l/min/m2), mean (SD) | 1.89 (0.6) | 1.91 (0.5) | 1.89 (0.6) | 0.70 |
| . | All (n = 310) . | GroupA (n = 98) . | GroupB (n = 212) . | P-Value . |
|---|---|---|---|---|
| Age (years), mean (SD) | 56.3 (13.6) | 55.0 (12.3) | 56.9 (14.1) | 0.26 |
| Female, n (%) | 74 (23.9) | 23 (23.5) | 51 (24.1) | 0.91 |
| Height (cm), mean (SD) | 174.5 (9.5) | 174.4 (9.0) | 174.6 (9.7) | 0.87 |
| Weight (kg), mean (SD) | 94.7 (25.4) | 95.6 (26.8) | 94.3 (24.8) | 0.66 |
| BSA, mean (SD) | 2.08 (0.3) | 2.08 (0.3) | 2.08 (0.3) | 0.86 |
| Hypertension, n (%) | 223 (71.9) | 67 (68.4) | 156 (73.6) | 0.34 |
| Dyslipidaemia, n (%) | 167 (53.9) | 47 (48.0) | 120 (56.6) | 0.16 |
| Diabetes mellitus, n (%) | 131 (42.3) | 38 (38.8) | 93 (43.9) | 0.40 |
| CVA, n (%) | 48 (15.5) | 14 (14.3) | 34 (16.0) | 0.69 |
| COPD, n () | 72 (23.2) | 18 (18.4) | 54 (25.5) | 0.16 |
| PVD, n (%) | 27 (8.7) | 3 (3.1) | 24 (11.3) | <0.01 |
| CHADS2 score, mean (SD) | 2.52 (1.1) | 2.40 (1.1) | 2.58 (1.1) | 0.19 |
| IABP, n (%) | 94 (30.3) | 29 (29.6) | 65 (30.7) | 0.85 |
| ECMO, n (%) | 18 (5.8) | 8 (8.2) | 10 (4.7) | 0.24 |
| HeartMate 3, n (%) | 137 (44.2) | 52 (53.1) | 85 (40.1) | 0.03 |
| History of atrial fibrillation, n (%) | 132 (42.6) | 42 (42.9) | 90 (42.5) | 0.95 |
| Previous cardiac surgery, n (%) | 75 (24.2) | 5 (5.1) | 70 (33.0) | <0.01 |
| Antiplatelet, n (%) | 161 (51.9) | 49 (50.0) | 112 (52.8) | 0.64 |
| Anticoagulation, n (%) | 152 (49.0) | 43 (43.9) | 109 (51.4) | 0.22 |
| Creatinin (mg/dl), mean (SD) | 1.56 (0.7) | 1.56 (0.8) | 1.56 (0.7) | 0.98 |
| LVDd (mm), mean (SD) | 70.6 (11.5) | 71.1 (11.4) | 70.4 (11.6) | 0.63 |
| Ejection fraction (%), mean (SD) | 19.7 (6.4) | 19.6 (6.4) | 19.7 (6.5) | 0.87 |
| Bridged to transplant, n (%) | 49 (15.8) | 16 (16.3) | 33 (15.6) | 0.46 |
| CVP (mmHg), mean (SD) | 13.8 (7.0) | 14.5 (7.0) | 13.5 (7.0) | 0.26 |
| Mean PAP (mmHg), mean (SD) | 38.9 (11.1) | 40.6 (11.1) | 38.1 (11.0) | 0.09 |
| PAWP (mmHg), mean (SD) | 26.4 (9.1) | 27.5 (8.6) | 25.9 (9.3) | 0.18 |
| PVR, mean (SD) | 3.66 (2.5) | 3.76 (2.5) | 3.62 (2.5) | 0.70 |
| CI (l/min/m2), mean (SD) | 1.89 (0.6) | 1.91 (0.5) | 1.89 (0.6) | 0.70 |
BSA: body surface area; CI: cardiac index; COPD: chronic obstructive pulmonary disease; CVA: cerebrovascular accident; CVP: central venous pressure; ECMO: extracorporeal membranous oxygenation; IABP: intra-aortic balloon pump; LVDd: left ventricular end-diastolic diameter; PAP: pulmonary artery pressure; PAWP: pulmonary artery wedge pressure; PVD: peripheral vascular disease; PVR: pulmonary vascular resistance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
